Clinical Trial Update: Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether psilocybin affects synaptic density in individuals with amnestic mild cognitive impairment; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amnestic Mild Cognitive Impairment

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Amnestic Mild Cognitive Impairment | Phase 2 | Status: ACTIVE_NOT_RECRUITING